New meta-analysis shows docetaxel benefits those having high grade/low PSA prostate cancer

[HikerWife]

Reposting with more specific title - no one had replied to Maxone73's original post. Interesting results for those with a poor-prognosis cancer. miragenews.com/docetaxel-sl...

[Gl448]

Thanks for reposting this. I'm a "high-grade low PSA" patient, so this high drop in mortality rate is encouraging news.

I did triplet therapy (docetaxel/lupron/nubeqa at the beginning of 2023. It took my PSA down from 0.944 to 0.014 after all six rounds. That was great, but it started doubling again almost monthly immediately after stopping docetaxel treatments. I appear to be castration resistant now. Waiting for the next PSA test after Thanksgiving to see if Provenge might be in my future, or something different.

[HikerWife in reply to Gl448]

Hoping that you find an effective treatment. Best of luck to you!